Pancreatic diseases
Conditions
Interventions
After positioning the side-view endoscope in the second portion of the duodenum at the time of endoscopic retrograde cholangiopancreatography, duodenal juice was collected for 5 minutes using PR-130Q
no protease inhibitor is added in the initial syringe and one protease inhibitor is added in the following another syringe. The sample is immediately put into 2mL-tube and stored at -80degrees.
Sponsors
Department of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Aged 20 or more year-old 2) Patients who undergo ERP and pancreatic juice cytology for their pancreatic diseases 3) Written informed consent
Exclusion criteria
Exclusion criteria: 1) Patients who have a history of severe complications due to ERP 2) Patients who have a history of complications due to secretin 3) Not written informed consent 4) Patients who the doctor-in-charge figures unsuitable for this study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The protein levels in the duodenal juice to detect patients with pancreatic cancer | — |
Countries
Japan
Contacts
Public ContactTakto Matsunaga
Graduate School of Medical Sciences, Kyushu University Department of Surgery and Oncology
Outcome results
None listed